Gastroesophageal Reflux Disease (GERD) Market to Grow Rapidly During the Forecast Period – DelveInsight | Key Companies – Jeil Pharmaceutical, Takeda, Sinorda Biomedicine, and AstraZeneca 1
Delveinsight Business Research LLP
DelveInsight’s “Gastroesophageal Reflux Disease Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Gastroesophageal Reflux Disease Market Size and Share in the 7MM (i.e. the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Gastroesophageal Reflux Disease market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current and forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market. 

Gastroesophageal Reflux Disease Market

Gastroesophageal Reflux Disease: An Overview

Gastroesophageal Reflux Disease (GERD) is a condition that develops when there is a retrograde flow of stomach contents back into the esophagus. It can present as a non-erosive reflux disease or erosive esophagitis. GERD is caused by multiple different mechanisms that can be intrinsic, structural, or both, leading to the disruption of the esophagogastric junction barrier resulting in exposure of the esophagus to acidic gastric contents.

The typical clinical presentation of GERD is heartburn and regurgitation. However, GERD can also present with various other symptoms that include dysphagia, odynophagia, belching, epigastric pain, and nausea.

Gastroesophageal Reflux Disease Market Key Facts

  • As per the article by Shams et al. (2009) titled “Gastroesophageal Reflux Disease in Older Adults: What Is the Difference?”, Gastroesophageal Reflux Disease (GERD) is one of the highly prevalent diseases seen in clinical practice. The prevalence (as defined by at least weekly heartburn and/or acid regurgitation) was 10-20% in the Western world and approximately 5% in Asia.

  • As per the article by Antunes et al. (2021), GERD is one of the most commonly diagnosed digestive disorders in the US with a prevalence of 20%, resulting in a significant economic burden in direct and indirect costs and adversely affecting the quality of life.

Gastroesophageal Reflux Disease Market

The increase in the prevalence of Gastroesophageal Reflux Disease (GERD), along with the expected launch of emerging therapies will boost the market growth during the forecasted period.

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Gastroesophageal Reflux Disease market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives a thorough detail of the Gastroesophageal Reflux Disease market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Gastroesophageal Reflux Disease Epidemiology

The epidemiology section covers insights into the historical and current Gastroesophageal Reflux Disease patient pool and forecasted trends for every seven major countries (7MM)  from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Gastroesophageal Reflux Disease Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Gastroesophageal Reflux Disease market or expected to get launched in the market during the study period. The analysis covers Gastroesophageal Reflux Disease market uptake by drugs; patient uptake by therapies; and sales of each drug. 

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allows the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Gastroesophageal Reflux Disease Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.

Request for Sample PDF Report –

Gastroesophageal Reflux Disease Therapeutics Analysis

The Gastroesophageal Reflux Disease (GERD) market dynamics is anticipated to change in the coming years owing to the rise in healthcare spending across the world.

Some of the key companies in the Gastroesophageal Reflux Disease (GERD) Market include:

  • Jeil Pharmaceutical Co. Ltd, 

  • Takeda, 

  • Sinorda Biomedicine 

  • AstraZeneca

And many others

Gastroesophageal Reflux Disease (GERD) Therapies Covered in the report include:

  • JP-1366

  • Dexlansoprazole

  • X842


And many more.

Get More Detailed Insights Into the Emerging Therapies & Key Companies –

Table of Content (TOC)

1. Key Insights

2. Executive Summary 

3. Gastroesophageal Reflux Disease Competitive Intelligence Analysis

4. Gastroesophageal Reflux Disease Market Overview at a Glance

5. Gastroesophageal Reflux Disease Disease Background and Overview

6. Gastroesophageal Reflux Disease Patient Journey

7. Gastroesophageal Reflux Disease Epidemiology and Patient Population

8. Gastroesophageal Reflux Disease Treatment Algorithm, Current Treatment, and Medical Practices

9. Gastroesophageal Reflux Disease Unmet Needs

10. Key Endpoints of Gastroesophageal Reflux Disease Treatment

11. Gastroesophageal Reflux Disease Marketed Products

12. Gastroesophageal Reflux Disease Emerging Therapies

13. Gastroesophageal Reflux Disease Seven Major Market Analysis

14. Attribute Analysis

15. Gastroesophageal Reflux Disease Market Outlook (7 major markets)

16. Gastroesophageal Reflux Disease Access and Reimbursement Overview

17. KOL Views on the Gastroesophageal Reflux Disease Market.

18. Gastroesophageal Reflux Disease Market Drivers

19. Gastroesophageal Reflux Disease Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF Report –

Other Latest Reports By DelveInsight

Metrorrhagia Market

DelveInsight’s “Metrorrhagia Market” report delivers an in-depth understanding of the historical and forecasted epidemiology, the Metrorrhagia market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan) as well as the emerging therapies and key companies in the therapeutic domain.

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States

Leave a Reply

Your email address will not be published.